Overview

A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia

Status:
Terminated

Trial end date:
2014-01-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the efficacy, safety and pharmacokinetics of intravenous conivaptan in pediatric subjects with abnormally low concentration of sodium in blood.

Phase:

Phase 3

Details

Lead Sponsor:

Cumberland Pharmaceuticals

Treatments:

Conivaptan